Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
Date first appeared online 04/05/2020
DOI 10.2337/dc19-2251
Authors Bain S.
Journal Name Diabetes Care
Volume

Documents